RxDoctor Payments Data

Hamed Emami, MD

Clinical Cardiac Electrophysiology · Stamford, CTNPI 1649650490

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (50.6%), food and beverage and grants — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Medtronic at 47.7% of the total. Reporting peaked in 2023 at $7,493 and has fallen 59.3% since, to $3,046 in 2025.

$20,407in general payments, 2019–2025

Across 117 payments — averaging $174.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$10K
  • Biotronik Inc.$7K
  • Medical Device Business Services, Inc.$1K
  • Abbott$1K
  • Boston Scientific$513
  • Biosense Webster, Inc.$103
  • plus $96 from 3 others

What the payments were for

  • Grants$4,85324%
  • Travel & lodging$10,32751%
  • Food & beverage$4,85424%
  • Education$3732%

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,407 in reported general payments places this provider in the 55th percentile of 47 clinical cardiac electrophysiology providers in Connecticut.

See all clinical cardiac electrophysiology providers in Connecticut

Medicare billing

Part B allowed, 2024
$169,707
Medicare patients
908
Services billed
2,413

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban56$73,396
Metoprolol Succinate56$816
Flecainide Acetate13$390

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Stamford

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →